Duration: 1 hour
Passive safety surveillance for post-marketed drugs is frequently undermined by incomplete, inconsistent and insufficient data. Safety scientists, epidemiologists and other researchers are increasingly integrating population-based real-world data (RWD) into all phases of their safety assessments to enhance the reliability of their data.
In our latest webinar, we'll discuss:
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing the on-demand webinar.Download Now
Enter the 6 digit code sent to your mobile number
Click on Resend the verification code again